Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Montali

Showing results (11-20 of 42) with videos related to

Pageof 5
Sort By:
Metabolism: Clinical and Experimental|October 24, 2007
Comparison of atorvastatin versus fenofibrate in reaching lipid targets and influencing biomarkers of endothelial damage in patients with familial combined hyperlipidemiaMarcello Arca, Anna Montali, Giovanni Pigna, et al.
Pediatric Research|January 22, 2010
Plasma non-cholesterol sterols: a useful diagnostic tool in pediatric hypercholesterolemiaDavide Noto, Angelo B Cefalù, Giacoma Barraco, et al.
Journal of Lipids|November 14, 2013
Association of RXR-Gamma Gene Variants with Familial Combined Hyperlipidemia: Genotype and Haplotype AnalysisFederica Sentinelli, Ilenia Minicocci, Anna Montali, et al.
The American Journal of Cardiology|November 13, 2007
Usefulness of atherogenic dyslipidemia for predicting cardiovascular risk in patients with angiographically defined coronary artery diseaseMarcello Arca, Anna Montali, Sofia Valiante, et al.
Free Radical Biology & Medicine|February 13, 2007
Increased plasma levels of oxysterols, in vivo markers of oxidative stress, in patients with familial combined hyperlipidemia: reduction during atorvastatin and fenofibrate therapyMarcello Arca, Silvia Natoli, Fausta Micheletta, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 2, 2008
C242T polymorphism of NADPH oxidase p22phox and recurrence of cardiovascular events in coronary artery diseaseMarcello Arca, Beatrice Conti, Anna Montali, et al.
Plos One|July 16, 2015
Correction: Atherogenic Dyslipidemia in Children: Evaluation of Clinical, Biochemical and Genetic AspectsAnna Montali, Gessica Truglio, Francesco Martino, et al.
Clinical Science (London, England : 1979)|August 1, 2015
Circulating miR-33a and miR-33b are up-regulated in familial hypercholesterolaemia in paediatric ageFrancesco Martino, Fabrizio Carlomosti, Daniele Avitabile, et al.
Plos One|April 22, 2015
Atherogenic dyslipidemia in children: evaluation of clinical, biochemical and genetic aspectsAnna Montali, Gessica Truglio, Francesco Martino, et al.
Heliyon|December 18, 2023
High CD49a+ NK cell infiltrate is associated with poor clinical outcomes in Hepatocellular CarcinomaAlessandra Zecca, Valeria Barili, Carolina Boni, et al.
Pageof 5

Showing results (11-20 of 42) with videos related to

Sort By:
Pageof 5
Metabolism: Clinical and Experimental|October 24, 2007
Comparison of atorvastatin versus fenofibrate in reaching lipid targets and influencing biomarkers of endothelial damage in patients with familial combined hyperlipidemiaMarcello Arca, Anna Montali, Giovanni Pigna, et al.
Pediatric Research|January 22, 2010
Plasma non-cholesterol sterols: a useful diagnostic tool in pediatric hypercholesterolemiaDavide Noto, Angelo B Cefalù, Giacoma Barraco, et al.
Journal of Lipids|November 14, 2013
Association of RXR-Gamma Gene Variants with Familial Combined Hyperlipidemia: Genotype and Haplotype AnalysisFederica Sentinelli, Ilenia Minicocci, Anna Montali, et al.
The American Journal of Cardiology|November 13, 2007
Usefulness of atherogenic dyslipidemia for predicting cardiovascular risk in patients with angiographically defined coronary artery diseaseMarcello Arca, Anna Montali, Sofia Valiante, et al.
Free Radical Biology & Medicine|February 13, 2007
Increased plasma levels of oxysterols, in vivo markers of oxidative stress, in patients with familial combined hyperlipidemia: reduction during atorvastatin and fenofibrate therapyMarcello Arca, Silvia Natoli, Fausta Micheletta, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 2, 2008
C242T polymorphism of NADPH oxidase p22phox and recurrence of cardiovascular events in coronary artery diseaseMarcello Arca, Beatrice Conti, Anna Montali, et al.
Plos One|July 16, 2015
Correction: Atherogenic Dyslipidemia in Children: Evaluation of Clinical, Biochemical and Genetic AspectsAnna Montali, Gessica Truglio, Francesco Martino, et al.
Clinical Science (London, England : 1979)|August 1, 2015
Circulating miR-33a and miR-33b are up-regulated in familial hypercholesterolaemia in paediatric ageFrancesco Martino, Fabrizio Carlomosti, Daniele Avitabile, et al.
Plos One|April 22, 2015
Atherogenic dyslipidemia in children: evaluation of clinical, biochemical and genetic aspectsAnna Montali, Gessica Truglio, Francesco Martino, et al.
Heliyon|December 18, 2023
High CD49a+ NK cell infiltrate is associated with poor clinical outcomes in Hepatocellular CarcinomaAlessandra Zecca, Valeria Barili, Carolina Boni, et al.
Pageof 5